A new scoring system to evaluate adjuvant chemotherapy for patients with T2N0M0 gastric cancer after D2 gastrectomy

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 28, Issue 38

Peer-Review Report of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Study

World J Gastroenterol. Oct 14, 2022; 28(38): 5626-5635
Published online Oct 14, 2022. doi: 10.3748/wjg.v28.i38.5626

Table 3 Multivariable Cox Proportional Hazards Modeling for overall survival

Clinicopathological features	HR (95%CI)	P value
Sex
Male	Reference
Female	0.390 (0.076-1.988)	P = 0.257
Smoking history
Yes	Reference
No	0.725 (0.308-1.710)	P = 0.463
Family history of gastric cancer
Yes	Reference
No	0.495 (0.058-4.224)	P = 0.521
BMI
18.5-23.9	Reference
> 23.9 or < 18.5	1.848 (0.760-4.490)	P = 0.175
Postoperative hospital stay
≤ 14 d	Reference
> 14 d	1.198 (0.350-4.100)	P = 0.960
Tumor site
Cardia cancer	Reference
Non-cardia gastric cancer	0.620 (0.277-1.390)	P = 0.246
The degree of differentiation
Poorly differentiated	Reference
Moderately differentiated	0.517 (0.206-1.300)	P = 0.161
Highly differentiated	0.390 (0.077-1.960)	P = 0.305
Vascular invasion
Yes	Reference
No	0.106 (0.045-0.246)	P < 0.001

HR: Hazard ratio; 95%CI: 95% confidence interval.

Citation: Xu Q, Kang WZ, Xiong JP, Shao XX, Li WK, Hu HT, Tian YT. A new scoring system to evaluate adjuvant chemotherapy for patients with T2N0M0 gastric cancer after D2 gastrectomy. World J Gastroenterol 2022; 28(38): 5626-5635
URL: https://www.wjgnet.com/1007-9327/full/v28/i38/5626.htm
DOI: https://dx.doi.org/10.3748/wjg.v28.i38.5626

Xu Q, Kang WZ, Xiong JP, Shao XX, Li WK, Hu HT, Tian YT. A new scoring system to evaluate adjuvant chemotherapy for patients with T2N0M0 gastric cancer after D2 gastrectomy. World J Gastroenterol 2022; 28(38): 5626-5635 [PMID: 36304088 DOI: 10.3748/wjg.v28.i38.5626]

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.